Blood test may predict liver cancer treatment success
NCT ID NCT07378709
First seen Jan 31, 2026 · Last updated May 13, 2026 · Updated 19 times
Summary
This study is looking at whether certain substances in the blood can help doctors predict how well a liver cancer treatment called TACE is working. About 15 adults with liver cancer who are scheduled for TACE will give blood samples before and after treatment. The goal is to see if changes in these blood markers match up with what the scans show about the tumor's response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KBC Bežanijska kosa
RECRUITINGBelgrade, Serbia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.